Loading…

Underestimation of Invasive Meningococcal Disease in Italy

Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the numbe...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2016-03, Vol.22 (3), p.469-475
Main Authors: Azzari, Chiara, Nieddu, Francesco, Moriondo, Maria, Indolfi, Giuseppe, Canessa, Clementina, Ricci, Silvia, Bianchi, Leila, Serranti, Daniele, Poggi, Giovanni Maria, Resti, Massimo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the number of cases misdiagnosed and diagnoses obtained postmortem with real-time PCR (rPCR), and we compared sensitivity of rPCR versus culture-based testing. A total of 222 IMD cases were identified: 11 (42%) of 26 fatal cases had been misdiagnosed or undiagnosed and were reclassified as IMD after rPCR showed meningococcal DNA in all available specimens taken postmortem. Of the samples tested with both rPCR and culture, 58% were diagnosed by using rPCR alone. The underestimation factor associated with the use of culture alone was 3.28. In countries such as Italy, where rPCR is in limited use, IMD incidence may be largely underestimated; thus, assessments of benefits of meningococcal vaccination may be prone to error.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2203.150928